Henry Wheeler | Head-Investor Relations |
Mondher Mahjoubi | Chief Executive Officer |
Joyson Karakunnel | Executive Vice President and Chief Medical Officer |
Yannis Morel | Executive Vice President-Business Development and Product Portfolio Strategy |
Yigal Nochomovitz | Citigroup |
Daina Graybosch | SVB Securities |
Swayampakula Ramakanth | HCW |
Hello, and thank you for standing by. My name is Regina and I will be your conference operator today. At this time I would like to welcome everyone to the Innate Pharma publication of revenue for Third Quarter 2022 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks there will be a question-and-answer session.